Redx Pharma plc Holding(s) in Company (4280K)
September 21 2016 - 3:51AM
UK Regulatory
TIDMREDX TIDMAV.
RNS Number : 4280K
Redx Pharma plc
21 September 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
------------------------------------------------------------------------
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: (ii)
---------------------------------------------------------------------------------------------------------------
2 Reason for the notification
(please tick the appropriate
box or boxes):
------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal Redx Pharma Plc
of voting rights
------------------------------------------------------------------- ------------------------------------------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already
issued to which voting rights are attached
---------------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------------- ---------------------------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------------- ---------------------------------------
Other (please specify):
---------------------------------------------------------------------- ---------------------------------------
3. Full name of person(s) subject to the
notification obligation: (iii)
---------------------------------------------------------------------- ---------------------------------------
4. Full name
of shareholder(s)
(if different
from 3.):(iv)
--------------------------------------------------------------- ----- ---------------------------------------
5. Date of the transaction Aviva plc & its subsidiaries
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------------- --------------------------------------------
6. Date on which issuer Registered Holder:
notified:
BNY Norwich Union Nominees
Limited 321,098*
Chase (GA Group) Nominees
Limited 4,685,774*
State Street Nominees Limited
1,216,783*
*denotes direct interest
Chase (GA Group) Nominees
Limited 319,659
Chase Nominees Limited 178,590
----------------------------------------------------------------- --------------------------------------------
7. Threshold(s) that is/are 19 September 2016
crossed or
reached: (vi, vii)
----------------------------------------------------------------- --------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------------- ------------------------------ ---------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------------- ------------------ ---------- ------------ ---------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------------- ------------------ ---------- ------------ ---------- ---------- ------- ----------
Ordinary
Shares
GB00BSNB6S51 7,754,352 7,754,352 6,721,904 6,223,655 498,249 6.65% 0.54%
------------------ ---------- ------------ ---------- ---------- ------- ----------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------- ------------------ ------------------------ ---------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
6,721,904 7.19%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
---------------------------------------------------------------
10. Name of the proxy holder: See Section 4
-------------------------------------------- -----------------
11. Number of voting rights proxy
holder will cease
to hold:
-------------------------------------------- -----------------
12. Date on which proxy holder will
cease to hold
voting rights:
-------------------------------------------- -----------------
13. Additional information: Figures are based on a total
number of voting rights of
93,552,638 as per the Company's
'Result of General Meeting
and Issue of Equity' Announcement
of 13 April 2016.
------------------------------- ------------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------- ------------------------------------
15. Contact telephone number: 01603 684420
------------------------------- ------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGRGDCRSDBGLB
(END) Dow Jones Newswires
September 21, 2016 03:51 ET (07:51 GMT)
Redx Pharma (LSE:REDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Redx Pharma (LSE:REDX)
Historical Stock Chart
From Apr 2023 to Apr 2024
